Jacob Gottlieb And His Success With Visium

Jacob Gottlieb’s reputation for healthcare investments was well known when he founded Visium. Jacob began investing when he was in his early teens. His hard work-ethic and supporting family gave him the motivation to succeed academically. Jacob Gottlieb graduated Brown University with a bachelor’s degree in Economics and a medical degree from the NYU School. After completing his medical internship, Jacob Gottlieb discovered a passion for finances and turned his focus for a career on Wall Street.

He began as an analyst for Sanford C. Bernstein & Co while simultaneously earning his Financial Analyst Certificate. In a few years, he began his new career as a healthcare portfolio manager at Merlin Biomed Group. Immediately following, he worked at Balyasny Asset Management where he became the top earner at the firm. His ambitious drive for a successful career made him create his own investment company Visium in 2005.

Founded by family and friends, Jacob Gottlieb had no trouble raising $300 million in seed capital from his trust with investors. There were high hopes for Visium since Jacob Gottlieb’s leadership and support for his talented portfolio managers and recruitment led to the company’s fund of $8 billion dollars with 170 employees across New York, London, and San Francisco.

Unfortunately, his success with Visium ended when three employees were charged with security mismarking and insider trading by the SEC and U.S Attorney’s Office in 2016. Their actions inflated returns and affected millions in management and performance fees. Due to the widespread panic and loss of employees, Jacob Gottlieb was forced to close down his company.

That didn’t stop Jacob from continuing his career as a health investor. His network with investors and reputable performance has led him to open an office in New York City where he began building his portfolio in investments with Oramed Pharmaceuticals Inc. and Sellas Life Sciences. His new chapter begins after the fruitful years he had with Visium.